Tiina Laurikainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tiina Laurikainen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Anita Arola
Department of Paediatrics and Adolescent Medicine, Turku University Hospital, Finland
2 shared publicationsAapo Sirén
1 shared publication- Aino Kivikallio
Department of Pathology and Institute of Biomedicine, Turku University Hospital and University of Turku, Finland
1 shared publication Andreina Kero
Department of Clinical Genetics, Turku University Hospital, Finland
1 shared publication- Hanna-Reeta Viljamaa
Department of Pediatric Surgery, Turku University Hospital and The Wellbeing Services County of Southwest Finland, Turku, Finland
1 shared publication Hendrik Rummel
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
Fatal Congenital Pulmonary Lymphangiectasis and Beckwith-Wiedemann Syndrome in a Newborn: A Case Report
Congenital pulmonary lymphangiectasis (CPL) is a rare developmental disorder characterized by the dilatation of the lymphatics of the lung. CPL can occur in a primary or secondary setting and has been reported in various genetic syndromes. Here, we describe a newborn with fatal CLP together with Beckwith-Wiedemann syndrome (BWS). The newborn presented with cyanosis soon after birth and died at the age of 3.5 hours due to severe hypoxemia leading to acidosis and cardiac dysfunction. Pathological examination revealed severe CLP as well as adrenal and pancreatic findings suggestive of BWS. The latter diagnosis was confirmed via methylation analysis, as the infant showed a sporadic maternal loss of methylation of IC2. To our knowledge, CPL has previously not been reported with BWS.
- 13 November 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
Open AccessFatal Congenital Pulmonary Lymphangiectasis and Beckwith-Wiedemann Syndrome in a Newborn: A Case Report
Congenital pulmonary lymphangiectasis (CPL) is a rare developmental disorder characterized by the dilatation of the lymphatics of the lung. CPL can occur in a primary or secondary setting and has been reported in various genetic syndromes. Here, we describe a newborn with fatal CLP together with Beckwith-Wiedemann syndrome (BWS). The newborn presented with cyanosis soon after birth and died at the age of 3.5 hours due to severe hypoxemia leading to acidosis and cardiac dysfunction. Pathological examination revealed severe CLP as well as adrenal and pancreatic findings suggestive of BWS. The latter diagnosis was confirmed via methylation analysis, as the infant showed a sporadic maternal loss of methylation of IC2. To our knowledge, CPL has previously not been reported with BWS.
- Open Access
- 3 November 2026
- Published by Elsevier in Ultrasound in Medicine & Biology
Intra- and Inter-Observer Reliability of Quantitative Brain Perfusion Metrics From Contrast-Enhanced Ultrasound in Neonatal Brain
- 3 November 2026
- Published by Elsevier in Ultrasound in Medicine & Biology
Open AccessIntra- and Inter-Observer Reliability of Quantitative Brain Perfusion Metrics From Contrast-Enhanced Ultrasound in Neonatal Brain
- Open Access
- 15 March 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (4) , 181
Diagnostic performance of contrast-enhanced voiding ultrasonography and direct radionuclide cystography with physiologic bladder filling volumes in pediatric vesicoureteral reflux—a prospective study
To compare the diagnostic performance of contrast-enhanced voiding ultrasonography (CEVUS) and direct radionuclide cystography (DRC) at physiological bladder filling volumes in pediatric patients with suspected vesicoureteral reflux (VUR). This prospective, comparative study included 22 children with 44 renal units referred for evaluation due to recurrent urinary tract infections (UTIs). Bladder function was assessed as normal through a four-hour voiding observation or uroflowmetry. All patients underwent both DRC and CEVUS on the same day, using a single catheterization. The investigations were performed by blinded radiologists. The primary outcome was VUR detection in relation to bladder filling volumes. Secondary outcomes included adverse effects and clinical outcomes in relation to radiological findings. DRC detected VUR in 72.7% of patients and 50.0% of renal units, while CEVUS detected VUR in 77.3% and 52.3% respectively. Among patients with paired bladder-filling data at first VUR detection, median bladder filling volume was 37.3% (IQR 26.7–82.4) of expected bladder capacity for DRC and 66.7% (IQR 52.9–87.3) for CEVUS (Wilcoxon signed-rank p = 0.158). At patient level, paired detection rates were comparable between modalities (exact McNemar p = 1.00). At the renal unit level, intermodality agreement was moderate (Cohen’s κ = 0.59; 95% CI 0.35–0.83). DRC detected VUR in 4 renal units negative on CEVUS, whereas CEVUS detected VUR in 5 renal units negative on DRC. Conclusion : CEVUS was comparable to DRC in VUR detection with physiological bladder filling volumes. As a radiation-free method providing anatomical detail while minimizing bladder overfilling, CEVUS offers a valuable alternative to VUR imaging. What is Known: • Voiding cystourethrography and direct radionuclide cystography are established imaging modalities for diagnosing vesicoureteral reflux, but both involve ionizing radiation. What is New: • Radiation-free contrast-enhanced voiding ultrasonography detects vesicoureteral reflux using physiologic bladder filling volumes with detection rates comparable to direct radionuclide cystography.
- 15 March 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (4) , 181
Open AccessDiagnostic performance of contrast-enhanced voiding ultrasonography and direct radionuclide cystography with physiologic bladder filling volumes in pediatric vesicoureteral reflux—a prospective study
To compare the diagnostic performance of contrast-enhanced voiding ultrasonography (CEVUS) and direct radionuclide cystography (DRC) at physiological bladder filling volumes in pediatric patients with suspected vesicoureteral reflux (VUR). This prospective, comparative study included 22 children with 44 renal units referred for evaluation due to recurrent urinary tract infections (UTIs). Bladder function was assessed as normal through a four-hour voiding observation or uroflowmetry. All patients underwent both DRC and CEVUS on the same day, using a single catheterization. The investigations were performed by blinded radiologists. The primary outcome was VUR detection in relation to bladder filling volumes. Secondary outcomes included adverse effects and clinical outcomes in relation to radiological findings. DRC detected VUR in 72.7% of patients and 50.0% of renal units, while CEVUS detected VUR in 77.3% and 52.3% respectively. Among patients with paired bladder-filling data at first VUR detection, median bladder filling volume was 37.3% (IQR 26.7–82.4) of expected bladder capacity for DRC and 66.7% (IQR 52.9–87.3) for CEVUS (Wilcoxon signed-rank p = 0.158). At patient level, paired detection rates were comparable between modalities (exact McNemar p = 1.00). At the renal unit level, intermodality agreement was moderate (Cohen’s κ = 0.59; 95% CI 0.35–0.83). DRC detected VUR in 4 renal units negative on CEVUS, whereas CEVUS detected VUR in 5 renal units negative on DRC. Conclusion : CEVUS was comparable to DRC in VUR detection with physiological bladder filling volumes. As a radiation-free method providing anatomical detail while minimizing bladder overfilling, CEVUS offers a valuable alternative to VUR imaging. What is Known: • Voiding cystourethrography and direct radionuclide cystography are established imaging modalities for diagnosing vesicoureteral reflux, but both involve ionizing radiation. What is New: • Radiation-free contrast-enhanced voiding ultrasonography detects vesicoureteral reflux using physiologic bladder filling volumes with detection rates comparable to direct radionuclide cystography.